USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: MICROCOSM, INC.
City: COLUMBIA
State: MD
Zip+4: 21045
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (410) 964-2775

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,470,077.00 5
SBIR Phase II $912,806.00 1

Award List:

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Henryk Malak
Award Amount: $199,993.00
Abstract:
Not Available Creare proposes an innovative small cryogenic cooler for future space missions, emphasizing high reliability, low cost, and very light weight. The cooler employs a pulse tube cold head and a thermo-compressor, eliminating the weight, expense, and reliability burden of the compressor… More

LOW-LIGHT, SMALL, FAST, HIGH-RES HYPERSPECTRAL IMAGER

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Henryk Malak
Award Amount: $94,359.00
Abstract:
DESCRIPTION (Applicant's abstract verbatim): Microcosm, Inc. has recently demonstrated a compact hyper spectral imaging method capable of rapidly analyzing every pixel in a CCD image with resolution in the nanometer range over a spectral width of several hundred… More

METALLIC NANOSENSOR MATRIX WITH ENHANCED FLUORESCENCE

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Henry K. Szmacinski
Award Amount: $399,915.00
Abstract:
DESCRIPTION (provided by applicant): Fluorescence is a dominant technology in medical testing, drug discovery, biotechnology and cellular imaging. There is demand for better fluorescent agents in terms of intensity, spectral range, functionality, photostability and phototoxicity. Recent trends in… More

Novel Micro-Nanoprobes and Detection Method for Biomedical Applications

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: DOE
Principal Investigator: Henryk Szmacinski, Dr.
Award Amount: $97,496.00
Abstract:
75586-The development and wide application of fluorescence-based technology to the detection and monitoring of biomolecule interactions is limited by the signal produced by the probe, the size of the biomolecules, and the detection technology. Highly desired real-time detection, without washing… More

Enhanced Fluorescent Detection of Pathogens

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Henryk Szmacinski
Award Amount: $678,314.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this application is the development of an ultrahigh sensitivity microarray platform for the simultaneous detection of many NIAID category A-C pathogens or pathogen byproducts. The application centers on the integration of two technologies; the… More

Enhanced Cancer Microarray

Award Year / Program / Phase: 2006 / SBIR / Phase II
Agency: HHS
Principal Investigator: Erik D. Brady
Award Amount: $912,806.00
Abstract:
DESCRIPTION (provided by applicant): The fight against cancer, heart disease, HIV, and all diseases are slow. Lives are being lost. The public spends over $1 trillion a year on health care. The government spends that much again. The tool used most in the fight against cancer employs fluorescent… More